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INTRODUCTION
The Cronkhite-Canada syndrome (CCS) is an infre-
quent disease, non-inherited, characterized by a gastroin-
testinal non-adenomatous polyposis, chronic diarrhea,
low blood proteins, malnutrition and skin and nail alter-
ations (1-6). Etiopathogeny is unknown, there is no effec-
tive treatment with a scientific base and, although cases
with response to empiric treatments have been described,
prognosis is usually poor. We do not know if with an ear-
ly diagnosis, the prognosis could be better. We expose a
new case of this enigmatic and infrequent disease, with
no medical treatment response, in order to remind it, im-
proving the casuistry and the available information about
it, and promoting, with a higher knowledge and diffusion,
an earlier treatment.
CASE REPORT
An 80 year-old-man was admitted to hospital com-
plaining of one month-history of weight loss, abdominal
pain and diarrhea. Family history: father and eight sib-
lings dead without previous digestive pathology. Person-
al history: no allergies, smoking (60 cigarettes/day) and
ethylic (80 g/day) habit until 25 years ago, appendecto-
my, high blood pressure, emphysematous chronic ob-
structive pulmonary disease, benign prostatic hypertro-
phy and generalized osteoarthritis. He was diagnosed
3 years ago of colonic diverticular disease with barium
enemas because of hypogastric pain. Colonoscopy study
was not realized and blood analysis did not show any sig-
nificant alteration. At this moment, total blood proteins
level was completely normal. Home treatment with tam-
sulosine, zolpidem tartrate, biotine, candesartan and in-
halated formoterol fulmarate, ipratropium bromide and
budesonide. He did not normally consume non-steroids
anti inflammatory drugs or antibiotics. In the last month,
because of the presence of diarrhea, he was treated with
loperamide and ciprofloxacin with no response.
—History of presenting complaint: over a period of
one month, he progressively presented: asthenia, anorex-
ia, weight loss (10 kg), numerous stools preceded by hy-
pogastric pain, with night and day rhythm, soft or liquid
consistence, without blood containing but plenty of mu-
cus. He did not refer fever, vomiting or any other interest-
ing symptoms.
—Physical examination: physical worsening attributed
to advanced age and muscle mass loss. Height 164 cm.
Weight 67 kg. He needed help for wandering. Absence of
jaundice or skin and mucosal paleness. Presence of hy-
perpigmented maculas in upper limbs. Poor body hair.
No peripheral adenopathies. Normal heart auscultation.
Heart frequency: 80 heartbeats per minute. Blood pres-
sure: 150/90 mmHg. Respiratory auscultation: diffuse
decrease of breath vesicular sounds with poor rhonchus
and sibilants. Normal abdominal auscultation with
painful palpation in hypogastric region and both iliac fos-
sas, without any mass or visceromegaly. Muscle atrophy
in limbs, normal peripheral pulse and absence of edemas.
—Blood test: hematocrit values, hemoglobine, mean
corpuscular volumen, platelets, glucose, urea, sodium,
creatinine, bilirrubine, transaminases, alcaline phos-
phatase, cholesterol, triglycerides, folic acid, ferritine and
B12 vitamin were steady in a normality range. Progres-
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sive elevation in leukocytes values (13,900-30,900, nor-
mal 4,600-10,200/mm3), with neutrocytophilia (70-90%),
and reactive C protein (16.9-93.4, normal 0-5 mg/L); de-
crease in total proteins values (4.4-5.3, normal 6.6-8.7
g/dl), calcium (4.7-7.0, normal 8.5-10.5 mg/dl) and
cholinesterase (1,557-2,591, normal 5,300-12,900 U/L).
Normal coagulation assay. Proteinogram: hypoalbumine-
mia (2.49, normal 4.0-4.7 g/dl) and hypogammaglobu-
linemia (0.39, normal 0.80-1.35 g/dl), with total proteins
4.7 g/dl. Potassium values, which were anodynes over the
first weeks of admission, reached values of 2.3-1.9, nor-
mal 3.5-5 mEq/L). Increased values of gastrin (263, nor-
mal 13-115 pg/ml) and thyrotropin (TSH) (33.9-17.3,
normal 0.12-5 uU/ml), decreased thyroxine (T4) (0.56-
0.27, normal 0.8-1.8 ng/dl) and normality of serum corti-
sol. TSH y T4 values were normal at admission. Thyroid
anti-peroxidase, anti-tiroglobulin, antinuclear and anti-
transglutaminase antibodies were negatives. Normal uri-
nary sediment. Elevation in carcinoembryonic antigen
(28.5-88.1, normal 0-5 ng/ml) and CA 19.9 antigen (57.8,
normal 0-37 U/ml) values; specific prostatic antigen,
alfa-fetoprotein and CA 125 antigen values were normal.
Fats quantification in stool tests was invaluable. Microbi-
ology: negativity in stool cultures, urine cultures, para-
sites in stools, Clostridium difficile toxine, mantoux, He-
licobacter pylori serology, HIV, citomegalovirus,
Salmonella and enterocolitic Yersinia.
—Ancillary tests:
• Colonoscopy (practiced twice): shows with a diffu-
sive distribution, mainly from rectosigmoid union up to
ileocecal valve, multiple nodular or sessile polypoid le-
sions, with variable sizes, reaching the total occupation
of the colon light in some zones, making difficult the en-
doscopy pass. Lesions show erythematous surface with
petechial and ecchymotic lesions. We obtained biopsies
from different levels and, in a second-time exploration, a
rectal macrobiopsy with polypectomy loop.
• Gastroscopy: esophagus, gastric fundus and body were
normal. Antral mucosa, mainly prepyloric, and duodenal
mucosa showed small nodes with a diffuse distribution.
• Thorax radiology: emphysematous blebs in right
lung base. No presence of pleural effusion. Suspicion
about the presence of pericardial effusion.
• Bariumize radiology of esophagus, stomach and
small bowel: antral gastric folds were bigger, irregulars
and with rounded filling defects. Small bowel folds were
as well increased, with a nodular pattern, mainly in je-
junum, and contrast dilution.
• Contrast enema: diverticulums in sigmoid and left
colon. Multiple filling defects throughout the colon.
• Abdominal computerized tomography: cysts in left
kidney. Probable right suprarenal adenoma. Diverticu-
lums in left and sigmoid colon. Diffuse enlargement of
colonic wall. Prostate hypertrophy.
• Thyroid echography: normal size of thyroid. Small
cysts in right lobe. Left lobe with homogeny and normal
echogenicity.
• Transthoracic echocardiogram: no images of peri-
cardial effusion, systolic function conserved, mitral and
aortic valve insufficiency.
• Colon biopsies and rectal macrobiopsy histology:
severe distortion in glandular architecture of mucosa, mi-
crocystic dilatations and mucin’s collections, edematous
lamina propria with moderate to severe inflammatory in-
filtration with numerous plasmatic cells, neutrophilles
and eosinophilles. These alterations detected are compat-
ible with the existence of colon and rectum hamartomas.
• Gastric and duodenal biopsies histology: we ob-
served glands dilatation with severe mixed inflammatory
infiltration, becoming the diagnosis of gastric and duode-
nal hamartomas.
—Clinical evolution: the patient is diagnosed of
Cronkhite-Canada syndrome, dying after two months of
hospital admission without detecting any clear improve-
ment of the initial clinic profile. He kept up the asthenia
and anorexia status, with a variable number of stools
plenty of mucous content, increasing the weight loss, and
persistent hypoproteinemia with edema in lower limbs.
He presented fever (38 ºC) some days with positive blood
cultures to E. coli related to phlebitis and urinary infec-
tions, a tetany episode, pain in lower limbs with a proba-
ble neuropathic origin and nail lesions with obvious ony-
cholysis. It is important to stand out the development of
hypothyroidism and the elevation of carcinoembryonic
antigen. The patient dies after 24 hours of cough with
cruentum sputum, dyspnea, respiratory insufficiency data
in arterial gasometry and a left base pneumonia in thorax
radiology. A necropsy was realized.
—Treatments: the patient, over his prolonged hospital
dwelling, received treatment, not simultaneously, with:
enteral nutrition, oral and by nasogastric tube, fluidother-
apy with supplementary potassium chloride, oral and sys-
temic calcium, intravenous albumin omeprazole 20
mg/day, mesalazine, vitamin complex, loratadine 10
mg/day, oral an systemic corticoids subcutaneous
octeotride 50 mcg/8 h, gabapentin 300 mg/8 h, antibiotics
(piperacillin-tazobactam, amoxicillin-clavulanic, metron-
idazole and ciprofloxacin), levothyroxine and medical
treatment of his previous basal pathology: high blood
pressure, chronic bronchopathy and prostate hypertrophy.
—Necropsy report: post-mortem examination discov-
eries coincided with the diagnosis of Cronkhite-Canada
syndrome.
—External examination: body hair decrease and dark
brown macular lesions in upper limbs, especially in the
back of the right hand and front side of left forearm. Both
hand fingers presented onycholysis with white-yellowed
nail pigmentation (Figs. 1 and 2). Bilateral hydrocele. Low-
er limbs edema.
—Internal examination: pericardial and peritoneal effu-
sions. Thyroid hypotrophy. Pulmonary emphysema and left
lung pneumonia. Bilateral nodular adrenal hyperplasia.
Moderate arterioesclerosis. Prostate adenocarcinoma local-
ized in both lobes without extracapsular or metastatic affec-
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tation. Testicular atrophy. There were no notable changes in
liver, biliary tract or pancreas. Digestive tract study: esopha-
gus without any abnormality. Gastric body showed a de-
crease of the folds. Gastric antrum showed a wrinkled sur-
face, “studded-like”, with a nodular increase of the folds and
superficial ecchymosis (Fig. 3), keeping these changes up to
second duodenal portion, where is more evident the pres-
ence of sessile polyps. In jejunum and ileum there was not
any significant disorder. Colonic mucosa showed, in its
whole extension, polypoid morphology, with multiple ses-
sile prominences, with ecchymotic surface and friable ap-
pearance. These alterations are less obvious in right colon.
Existence of diverticulums in left colon.
Microscopically it was striking the antrum, duodenum,
colon and rectum affectation (in their entirety), showing
similar histopathology, with the presence of multiple poly-
poid formations, some of them hamartomatous, with en-
larged and cystic crypts, decreased in number and with
mucus hypersecretion. In lamina propria we observed ede-
ma with muscularis mucosa fibers hyperplasia, and chron-
ic low-moderated inflammation (Figs. 4 and 5). There is a
reduction of intestinal villi in duodenum and colon, and a
gastric fundus and body folds decrease. We did not recog-
nize any dysplasia sign in any of the observed cuts.
Death cause: severe malnutrition due to Cronkhite
Canada syndrome. Left lung pneumonia.
DISCUSSION
The Cronkhite Canada syndrome (CCS) was described
for first time in 1955, and it is characterized by a clinical
picture of chronic diarrhea with hypoproteinemia and
malnutrition, alopecia, skin pigmentation and onychody-
strophy (1-6). In stomach, small bowel and colon, but not
in esophagus, multiple hamartomatous polyps are detect-
ed. They are sessile polyps with superficial erosions. At
microscopy show lamina propria edema and cystic glan-
dular enlargement with accumulation of mucinous mater-
ial, polymorphonuclear aggregates and lymphoplasma-
cytic and eosinophilic inflammatory infiltrates (1,2,5-10).
In some cases it has been described the existence of an
outstanding mast cells infiltrate (1,2,6). Skin pigmenta-
tion shaped like brown macular lesions because of the ac-
cumulation of melanin in basal layer, use to be demon-
strated in limbs, palms, plants, face and neck (1-6,11).
Nails show dystrophic changes and, in advanced cases,
easily detached themselves from nail bed. CCS is includ-
ed in the differential diagnosis of the gastrointestinal
polyposis, non adenomatous and non inherited, as lym-
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Fig. 1. Onycholysis with white - yellowed thumbnail discoloration.
Onicólisis con decoloración ungueal blanquecino-amarillenta.
Fig. 2. Maculas with brown dark coloration in frontal region of left fo-
rearm.
Máculas de coloración pardo-oscuras en región anterior de antebrazo
izquierdo.
Fig. 3. Gastric mucosa with polypoid morphology, with multiple sessile
prominences and ecchymotic surface.
Mucosa gástrica con morfología polipoidea, con múltiples prominen-
cias sésiles y de superficie equimótica.
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phoid nodular hyperplasia and hyperplasic, inflammato-
ry, lipomatous or lymphomatous polyposis (1-3,8,12-16). It
is a very infrequent disease, at least in occidental coun-
tries, leading most of published cases to Asiatic coun-
tries. In Spain we have just two reference of reported cas-
es (2,3), while in Japan there have been published
reviews with over one hundred cases. Etiopathology of
CCS is still unknown (2,4,14). Histological data and the
occasional response to treatments with antibiotics or cor-
ticoids, guide us to a disease with an inflammatory base
that could be influenced in some way by bacterial agents
(1,2,8,11). Recently it has been published a possible rela-
tion to the Helicobacter pylori infection (17). It is a dis-
ease with poor prognosis (1,2,11,16,18). Most of patients
with CCS die because of a severe malnutrition picture,
frequently complicated with infections (1,2,5,9,10). It has
been described remissions of the disease after improving
nutritional status and restoring the electrolytes disorders
of these patients (1,2,6,8-11), as well as using the associ-
ation of drugs like antibiotics (ampicillin, tetracyclines,
metronidazole, ciprofloxacin, etc.) (1,7), oral and intra-
venous corticoids (1,2,6,8-11), H1 and H2 receptor an-
tagonists of histamine (loratadine and ranitidine) (8), an-
tidiarrheal drugs or disodium cromoglycate. There is no
doubt about the need of nutritional treatment, oral or par-
enteral, as well as the control of ionic and trace elements
deficiency. The mentioned pharmacological treatment, in
the other hand, is totally empiric, with no scientific evi-
dence, and its results are completely unpredictable. There
is the possibility, especially in cases with localized and
not very extended affection, of extirpating the intestinal
segment affected. It has been reported one case of im-
provement after hemicolectomy (1,2,10).
CCS is not considered a gastrointestinal premalignant
disease, however is remarkable a relatively frequent com-
munication of patients with colonic adenocarcinoma or
with adenomatous changes in these hamartomatous
polyps (1,6,7,12,13).
Our patient presented the typical medical picture of
CCS without improvement despite medical treatment
similar to those described by other authors with better re-
sults, dying in a situation of malnutrition, respiratory in-
sufficiency and sepsis related to pneumonia. We stand
out, like other published case reports (11,19,20), the de-
velopment of hypothyroidism, initially related to malnu-
trition and, on the other hand, the increase of CEA with-
out detecting in the practiced studies, including necropsy,
dates of digestive neoplasm, beyond the prostate neo-
plasm.
The infrequency of CCS and the numerous doubts
aroused, especially about etiopathogenesis and treatment,
motive the divulgation of clinical reports of this disease
in order to remind it, improve knowledge of it increasing
casuistry and promoting earlier diagnosis, previous to the
instauration of severe malnutrition, and trying to improve
the prognosis.
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